Key result
Early comprehensive pharmacological treatment with immunosuppressive and anticoagulant therapy led to the disappearance of tricuspid regurgitation and Libman-Sacks vegetation within 28 days without necessitating cardiac surgery.
Why the study?
Libman-Sacks endocarditis is relatively rare in children, and managing established vegetation is challenging and often necessitates surgical intervention.
Does a combination of immunosuppressive and anticoagulant therapy resolve Libman-Sacks endocarditis vegetation in a pediatric patient with systemic lupus erythematosus?
Case Report (n=1)
Does a combination of immunosuppressive and anticoagulant therapy resolve Libman-Sacks endocarditis vegetation in a pediatric patient with systemic lupus erythematosus?
A combination of immunosuppressive and anticoagulant therapy successfully resolved Libman-Sacks endocarditis vegetation in a 14-year-old with SLE, suggesting a viable non-surgical management model.
Answers are grounded in this paper and cite their sources.
May support non-surgical management of pediatric Libman-Sacks endocarditis; leaves open need for prospective validation before practice change.
Libman-Sacks endocarditis (LSE) is a cardiac condition characterized by the growth of verrucous vegetation. Although relatively rare in children, LSE is nevertheless a known cardiac manifestation of autoimmune diseases, including systemic lupus erythematosus (SLE). The mitral valve is the most commonly affected region, followed by the aortic valve, while the tricuspid and pulmonary valves are rarely affected. The management of established Libman-Sacks vegetation poses significant challenges, often necessitating surgical interventions, although surgery is not the primary treatment modality. Herein, we present the case of a 14-year-old Chinese female patient whose initial lupus manifestation included LSE, among other symptoms and signs that provided insights into the final diagnosis of SLE. After early comprehensive pharmacological treatment, tricuspid regurgitation and vegetation disappeared within 28 days without necessitating cardiac surgery, indicating that the resolution of LSE vegetation in this patient was achieved through a combination of immunosuppressive and anticoagulant therapy. These findings suggest the potential of this treatment approach as a viable model for the management of LSE in young patients.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2024) conducted a case report in Libman-Sacks endocarditis in systemic lupus erythematosus (n=1). Immunosuppressive and anticoagulant therapy was evaluated on Resolution of tricuspid regurgitation and vegetation. Early comprehensive pharmacological treatment with immunosuppressive and anticoagulant therapy led to the disappearance of tricuspid regurgitation and Libman-Sacks vegetation within 28 days without necessitating cardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: